SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Bristol Myers Squibb at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Bristol Myers Squibb brings 4 presentations to SITC 2026 in Phoenix. Its program centres on new drugs in development and on the company's approach to scientific opportunity and partnerships. The most concrete item is iza-bren, its first bispecific antibody-drug conjugate, alongside pumitamig, an antibody that blocks both PD-L1 and VEGF-A.

OrganizationSITC 2026 Attendance
Large pharma
Global pharmaceutical company whose immuno-oncology medicines include the checkpoint inhibitors nivolumab and ipilimumab.
Session
Thu Nov 5
6:45pm–7:20pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Bristol Myers Squibb

Tell us what you sell and we’ll find the people at Bristol Myers Squibb most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction